Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Patient information on managing pain
File results
-
FOI/2021/0463 - Staff accommodation
-
FOI/2021/0466 - Patient wait of more than 52 weeks for elective treatment
-
FOI/2021/0467 - Celebration of Pride in 2020 and 2021
-
FOI/2021/0468 - Patient data management system
-
FOI/2021/0475 - Covid-19 deaths
-
FOI/2021/0485 - Patient transport policy
-
FOI/2021/0490 - Greener NHS National Programme
-
FOI/2021/0494 - Maternity patients not eligible for free healthcare
-
FOI/2021/0499 - Cancer pathway started treatment
-
FOI/2021/0502 - Maternity and Neonates